— Know what they know.
Not Investment Advice
Also trades as: 2432.T (JPX) · $vol 20M

DNACF OTC

DeNA Co., Ltd.
1W: +0.0% 1M: +9.4% 3M: +2.2% YTD: +1.2% 1Y: +10.8% 3Y: +66.5% 5Y: -3.4%
$16.35
+0.00 (+0.00%)
 
OTC · Technology · Software - Application · Tech Score Buy · Power 66 · $1.5B mcap · 46M float · 0.0001% daily turnover · Short 100% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A+
Oct 02, 2026
DCF
4
ROE
4
ROA
5
D/E
3
P/E
4
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DNACF receives an overall rating of A+. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5), P/E (4/5), P/B (4/5).
Rating Change History
DateFromTo
2026-08-07 A- A+
2026-08-04 A A-
2026-07-25 A- A
2026-06-30 None ADDED
2026-06-06 EXISTED None
2026-06-01 None ADDED
2026-05-20 EXISTED None
2026-05-15 None ADDED
2026-05-13 EXISTED None
2026-05-08 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A
Profitability
35
Balance Sheet
88
Earnings Quality
74
Growth
17
Value
—
Momentum
52
Safety
—
Cash Flow
61

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✓ ✓ ✓ ✗ ✗
Beneish M-Score
-2.81
Unlikely Manipulator
Ohlson O-Score
-11.36
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 75.2/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.39x
Accruals: -2.0%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DNACF scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DNACF's score of -2.81 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DNACF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DNACF receives an estimated rating of A+ (score: 75.2/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). DNACF's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
6.27x
PEG
0.16x
P/S
1.97x
P/B
1.16x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$2916.51
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 6.3x earnings, DNACF trades at a deep value multiple. Graham's intrinsic value formula yields $2916.51 per share, suggesting a potential 17738% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.740
NI / EBT
×
Interest Burden
1.314
EBT / EBIT
×
EBIT Margin
0.133
EBIT / Rev
×
Asset Turnover
0.407
Rev / Assets
×
Equity Multiplier
1.533
Assets / Equity
=
ROE
8.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DNACF's ROE of 8.1% is driven by Asset Turnover (0.407), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$6783.80
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with DNACF's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. DNACF actually compounded EPS at 30.4% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. DNACF trades at a premium to its adjusted intrinsic value of $6783.80, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 6.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$16.35
Median 1Y
$14.54
5th Pctile
$6.64
95th Pctile
$32.10
Ann. Volatility
46.6%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 14.2% 13.2% 13.3% 13.2% 9.9% 8.2% 4.9% 3.8% 2.7% 2.2% -13.9% -13.3% -13.6% -15.0% 8.5% 10.7% 13.5% 42.5% 10.6% 8.1% 8.08%
ROA 9.8% 9.1% 9.4% 9.1% 7.0% 5.6% 3.4% 2.6% 1.9% 1.5% -9.0% -8.4% -8.9% -9.9% 5.5% 6.6% 8.7% 27.3% 7.0% 5.3% 5.27%
ROIC 8.3% 7.5% 6.5% 6.3% 7.5% 3.3% 0.7% 1.6% 0.7% 0.6% -0.2% 0.1% 0.2% 0.7% 7.3% 10.8% 13.1% -77.6% 12.2% 14.3% 14.31%
ROCE 11.7% 11.8% 11.6% 10.9% 8.8% 6.9% 4.7% 5.5% 3.7% 3.2% -7.2% 2.1% 0.7% 0.5% 15.9% 10.8% 13.2% -86.4% 9.7% 7.3% 7.31%
Gross Margin 53.1% 52.6% 47.6% 47.8% 49.9% 49.5% 42.9% 47.0% 47.4% 47.8% 37.6% 44.0% 47.7% 48.7% 62.9% 62.4% 59.5% 57.2% 47.3% 48.2% 48.23%
Operating Margin 16.1% 23.1% 7.2% -12.9% 11.4% 8.5% -6.7% -2.5% 4.8% 8.1% -15.3% -0.3% 5.6% 11.3% 33.3% 16.9% 33.1% 27.3% 6.4% 5.5% 5.46%
Net Margin 42.4% 24.2% 12.8% 12.2% 20.5% 10.8% -12.6% 4.7% 12.8% 7.1% -1.3% 7.8% 9.0% -0.1% 27.5% 17.9% 26.8% 28.5% -19.8% 6.7% 6.70%
EBITDA Margin 56.0% 36.2% 19.7% -2.8% 34.8% 19.1% -2.0% 9.4% 20.5% 15.5% -1.0% 90.7% 9.1% 13.3% 36.1% 28.8% 37.2% 31.4% -17.8% 11.1% 11.10%
FCF Margin 18.1% 15.4% 12.0% 9.1% 7.2% 8.4% 5.0% 2.4% -4.7% -11.6% -14.0% -15.6% -6.9% 2.0% 5.8% 21.2% 16.6% 16.3% 23.5% 13.5% 13.45%
OCF Margin 22.4% 20.2% 16.8% 14.0% 12.0% 13.2% 10.1% 8.0% 1.0% -4.2% -6.3% -7.9% 0.2% 6.2% 8.8% 23.8% 18.6% 18.4% 27.2% 18.0% 17.98%
ROE 3Y Avg snapshot only 1.50%
ROE 5Y Avg snapshot only 4.24%
ROA 3Y Avg snapshot only 1.11%
ROIC 3Y Avg snapshot only 2.70%
ROIC Economic snapshot only 8.46%
Cash ROA snapshot only 7.96%
Cash ROIC snapshot only 18.30%
CROIC snapshot only 13.69%
NOPAT Margin snapshot only 14.05%
Pretax Margin snapshot only 17.48%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 34.99%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 6.267
P/S Ratio — — — — — — — — — — — — — — — — — — — — 1.966
P/B Ratio — — — — — — — — — — — — — — — — — — — — 1.164
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.160
Graham Number snapshot only $2916.51
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 3.50 2.95 3.62 1.97 2.58 1.77 1.71 2.63 3.33 3.49 3.13 2.32 2.54 2.69 2.69 1.61 1.80 0.01 1.96 2.25 2.248
Quick Ratio 3.50 2.95 3.62 1.97 2.58 1.77 1.71 2.63 3.33 3.49 3.13 2.32 2.54 2.69 2.69 1.61 1.80 0.01 1.96 2.25 2.248
Debt/Equity 0.12 0.13 0.13 0.12 0.12 0.19 0.20 0.20 0.19 0.19 0.22 0.21 0.22 0.21 0.20 0.20 0.18 24.92 0.23 0.07 0.066
Net Debt/Equity -0.28 -0.21 -0.22 -0.21 -0.42 -0.28 -0.26 -0.24 -0.19 -0.17 -0.16 -0.13 -0.12 -0.15 -0.12 -0.18 -0.15 -27.40 -0.16 -0.38 -0.377
Debt/Assets 0.08 0.09 0.09 0.08 0.08 0.13 0.13 0.13 0.12 0.13 0.14 0.13 0.14 0.14 0.13 0.12 0.12 16.86 0.16 0.05 0.046
Debt/EBITDA 0.76 0.86 0.83 0.77 0.96 1.83 2.56 2.09 2.56 2.72 -3.23 3.51 5.51 6.25 0.86 1.26 0.97 0.78 1.59 0.58 0.579
Net Debt/EBITDA -1.82 -1.36 -1.44 -1.37 -3.37 -2.77 -3.33 -2.45 -2.68 -2.54 2.30 -2.15 -3.04 -4.48 -0.50 -1.17 -0.79 -0.86 -1.07 -3.29 -3.286
Interest Coverage 92.31 34.20 41.28 19.30 14.19 18.77 3.47 5.87 4.27 3.63 -8.08 2.40 0.79 0.29 21.79 9.58 13.26 39.78 20.85 5.84 5.840
Equity Multiplier 1.42 1.44 1.41 1.42 1.40 1.48 1.51 1.57 1.49 1.48 1.57 1.60 1.57 1.56 1.54 1.63 1.52 1.48 1.49 1.43 1.433
Cash Ratio snapshot only 1.601
Debt Service Coverage snapshot only 7.927
Cash to Debt snapshot only 6.677
FCF to Debt snapshot only 1.287
Defensive Interval snapshot only 980.7 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 0.46 0.42 0.41 0.39 0.40 0.40 0.40 0.39 0.40 0.40 0.42 0.40 0.40 0.39 0.45 0.45 0.46 1.09 0.45 0.41 0.407
Inventory Turnover — 1082.77 1009.70 — — — — — — — — — — — — — — — — — —
Receivables Turnover 6.61 5.87 6.28 5.07 6.45 6.69 6.97 5.19 6.71 6.92 6.96 4.74 6.89 6.72 5.07 4.40 7.40 19.15 5.26 3.89 3.887
Payables Turnover 3.89 3.15 3.58 3.30 4.08 3.67 4.48 3.66 4.32 4.14 4.56 3.72 4.42 4.26 4.20 3.18 4.57 8.12 4.19 2.94 2.945
DSO 55 62 58 72 57 55 52 70 54 53 52 77 53 54 72 83 49 19 69 94 93.9 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 94 116 102 110 89 100 82 100 84 88 80 98 83 86 87 115 80 45 87 124 124.0 days
Cash Conversion Cycle -39 -53 -43 -38 -33 -45 -29 -29 -30 -35 -28 -21 -30 -31 -15 -32 -30 -26 -18 -30 -30.1 days
Fixed Asset Turnover snapshot only 4.094
Cash Velocity snapshot only 1.432
Capital Intensity snapshot only 2.258
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 17.4% 9.1% 0.0% -4.5% -6.7% -1.7% -0.0% 3.1% 3.6% 3.6% 3.4% 1.3% -1.3% -5.0% 8.5% 19.9% 27.6% 34.6% 8.7% -9.4% -9.43%
Net Income 1.7% 1.8% 32.3% 19.1% -23.1% -35.1% -63.3% -71.0% -72.6% -72.7% -3.7% -4.2% -5.8% -7.4% 1.6% 1.8% 2.1% 2.3% 38.9% -20.5% -20.54%
EPS 1.7% 1.9% 37.9% 23.6% -21.6% -34.4% -61.9% -69.2% -70.9% -71.3% -3.7% -4.2% -5.8% -7.4% 1.6% 1.8% 2.1% 2.3% 38.9% -18.7% -18.67%
FCF 8.9% 2.2% 18.1% -42.3% -62.8% -46.1% -58.5% -73.0% -1.7% -2.4% -3.9% -7.6% -43.5% 1.2% 1.4% 2.6% 4.1% 10.2% 3.4% -42.5% -42.49%
EBITDA 2.8% 3.6% -2.9% 13.8% -16.2% -29.8% -49.4% -41.0% -43.0% -34.1% -1.8% -41.4% -50.7% -55.6% 5.0% 2.0% 5.1% 7.3% -32.3% -29.9% -29.91%
Op. Income 1.4% 1.5% -46.5% -49.0% -35.3% -65.2% -92.5% -63.3% -80.2% -61.5% -1.4% -92.4% -74.6% -27.4% 51.5% 91.4% 81.6% 32.6% 65.0% -1.3% -1.26%
OCF Growth snapshot only -31.53%
Asset Growth snapshot only -14.93%
Equity Growth snapshot only -3.16%
Debt Growth snapshot only -67.92%
Shares Change snapshot only -2.29%
Dividend Growth snapshot only 2.33%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y 1.0% 0.5% 1.4% 1.8% 2.7% 3.4% 3.3% 3.6% 4.3% 3.6% 1.1% -0.1% -1.5% -1.1% 3.9% 7.8% 9.3% 9.8% 6.8% 3.3% 3.26%
Revenue 5Y -0.5% -1.3% -1.5% -1.9% -1.5% -1.0% -1.2% -0.7% -0.1% 0.7% 1.5% 2.0% 2.0% 1.7% 4.4% 6.2% 7.4% 7.3% 4.0% 1.6% 1.63%
EPS 3Y 16.6% 17.1% 65.5% 43.4% 42.1% 44.1% — — — — — — — — -13.8% -5.6% 13.9% 35.0% 32.7% 30.4% 30.45%
EPS 5Y 20.2% 17.8% 3.2% 4.0% -1.7% -4.7% -10.6% -12.9% -18.4% -21.3% — — — — — — — — 4.2% -3.3% -3.30%
Net Income 3Y 9.7% 9.4% 54.6% 33.9% 32.8% 34.2% — — — — — — — — -15.5% -7.5% 11.7% 32.8% 31.6% 29.5% 29.48%
Net Income 5Y 15.9% 13.1% -0.9% -0.2% -5.6% -8.8% -14.8% -17.4% -22.6% -25.4% — — — — — — — — 2.1% -5.6% -5.59%
EBITDA 3Y -5.5% -5.9% 8.7% 6.7% 2.4% -1.2% — — — — — -26.7% -38.2% -41.0% 16.1% 1.5% 19.6% 34.5% 27.9% 7.5% 7.50%
EBITDA 5Y -0.1% -0.8% -0.9% 0.5% -3.1% -6.5% -16.5% -11.8% -16.6% -17.3% — -15.9% -21.3% -22.4% — — — — 0.6% -3.6% -3.57%
Gross Profit 3Y -1.5% -2.4% -1.4% -1.0% -0.2% 0.7% 0.3% 0.7% 1.3% -0.8% -4.8% -6.6% -7.8% -6.3% 4.2% 12.0% 15.8% 18.1% 13.6% 7.6% 7.59%
Gross Profit 5Y -2.2% -3.8% -4.6% -5.5% -5.3% -5.1% -5.5% -4.8% -4.5% -3.6% -2.7% -2.1% -1.8% -1.6% 4.2% 8.1% 10.5% 10.2% 5.2% 1.3% 1.27%
Op. Income 3Y -16.3% -15.3% 8.9% -5.3% -2.4% -13.0% — — — — — -75.8% -68.1% -54.0% 18.8% 37.0% 60.8% 1.1% 2.3% 90.6% 90.64%
Op. Income 5Y -7.8% -8.8% -11.7% -13.1% -14.8% -24.8% -50.1% -31.3% -40.4% -39.4% — -52.7% -45.8% -28.7% — — — — 8.2% 5.3% 5.30%
FCF 3Y 19.8% 41.5% 23.7% 60.2% 55.7% — — — — — — — — -50.2% -18.6% 42.8% 44.3% 36.7% 79.0% 83.6% 83.63%
FCF 5Y 17.1% 13.4% 12.3% 9.2% -6.9% -7.3% -20.9% -30.1% — — — — — — — — — 34.4% 23.0% -0.7% -0.70%
OCF 3Y -2.0% 0.1% -6.8% -7.2% -11.5% -2.9% -4.0% -5.8% -50.8% — — — -80.8% -33.1% -16.3% 28.5% 26.4% 22.5% 48.5% 35.2% 35.18%
OCF 5Y 4.7% 1.8% -0.8% -4.1% -11.2% -11.1% -18.7% -22.1% -46.9% — — — -60.3% -15.7% -3.0% 24.7% 21.9% 12.6% 13.9% -2.3% -2.28%
Assets 3Y 1.9% -0.3% 1.7% 4.7% 2.1% 3.5% 8.8% 10.9% 6.8% 2.7% -1.1% 0.9% 0.4% -0.2% 3.3% 5.0% 7.0% -80.2% 3.5% -1.3% -1.32%
Assets 5Y 5.8% 3.5% 1.7% 2.7% 1.2% 1.6% 0.6% 0.3% 2.2% 1.2% 0.7% 2.5% 1.2% 0.3% 6.1% 9.0% 7.5% -61.4% 2.7% 0.5% 0.50%
Equity 3Y -2.7% -4.9% -2.3% -1.5% -2.9% -2.9% 4.8% 7.1% 6.2% 2.5% -4.0% -2.2% -2.9% -2.8% 0.1% 0.2% 4.0% -80.2% 3.9% 1.8% 1.84%
Book Value 3Y 3.5% 1.9% 4.6% 5.5% 4.0% 4.2% 11.7% 12.7% 10.1% 6.1% -0.6% 1.1% -0.3% -0.8% 2.2% 2.2% 6.1% -79.8% 4.8% 2.6% 2.61%
Dividend 3Y 21.9% 24.1% 24.1% 24.0% 13.2% 13.5% 12.7% 11.3% -18.0% -18.8% -18.8% -18.9% 1.9% 2.1% 2.1% 2.0% 50.5% 50.5% 49.4% 49.3% 49.26%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.16 0.30 0.18 0.13 0.02 0.01 0.05 0.01 0.01 0.19 0.86 0.59 0.34 0.45 0.92 0.77 0.70 0.56 0.76 0.39 0.395
Earnings Stability 0.09 0.10 0.01 0.01 0.02 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.01 0.04 0.06 0.09 0.08 0.10 0.02 0.05 0.047
Margin Stability 0.94 0.94 0.94 0.93 0.92 0.92 0.92 0.92 0.91 0.92 0.91 0.91 0.91 0.93 0.94 0.91 0.89 0.88 0.90 0.90 0.901
Rev. Growth Consistency 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.000
FCF Positive Streak 0 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0
Earnings Persistence 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.500
Earnings Smoothness — — 0.72 0.83 0.74 0.57 0.07 0.00 0.00 0.00 — — — — — — — — 0.67 0.77 0.771
ROE Trend 0.22 0.19 0.20 0.21 0.14 0.10 -0.07 -0.08 -0.09 -0.08 -0.24 -0.22 -0.20 -0.21 0.13 0.15 0.18 24.03 0.13 0.10 0.101
Gross Margin Trend 0.02 -0.00 -0.02 -0.03 -0.03 -0.04 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.03 0.05 0.10 0.13 0.15 0.09 0.03 0.032
FCF Margin Trend 0.18 0.13 0.09 0.02 -0.00 -0.02 -0.06 -0.10 -0.17 -0.23 -0.23 -0.21 -0.08 0.04 0.10 0.28 0.22 0.21 0.28 0.11 0.107
Sustainable Growth Rate 12.3% 11.4% 11.6% 11.5% 7.9% 6.2% 2.9% 1.8% 1.7% 1.2% — — — — 7.5% 9.7% 10.5% 35.6% 7.6% 5.0% 5.03%
Internal Growth Rate 9.3% 8.5% 8.9% 8.7% 5.9% 4.4% 2.0% 1.2% 1.2% 0.8% — — — — 5.0% 6.4% 7.3% 29.7% 5.2% 3.4% 3.40%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 1.05 0.94 0.74 0.60 0.68 0.94 1.21 1.22 0.22 -1.12 0.29 0.38 -0.01 -0.25 0.72 1.61 0.99 0.73 1.73 1.39 1.389
FCF/OCF 0.81 0.76 0.72 0.65 0.60 0.64 0.49 0.30 -4.55 2.77 2.21 1.97 -41.32 0.31 0.66 0.89 0.89 0.88 0.86 0.75 0.748
FCF/Net Income snapshot only 1.039
OCF/EBITDA snapshot only 0.995
CapEx/Revenue 4.3% 4.8% 4.7% 4.9% 4.8% 4.8% 5.1% 5.6% 5.8% 7.4% 7.7% 7.7% 7.0% 4.3% 3.0% 2.6% 2.0% 2.1% 3.7% 4.5% 4.52%
CapEx/Depreciation snapshot only 0.951
Accruals Ratio -0.00 0.01 0.02 0.04 0.02 0.00 -0.01 -0.01 0.01 0.03 -0.06 -0.05 -0.09 -0.12 0.02 -0.04 0.00 0.07 -0.05 -0.02 -0.020
Sloan Accruals snapshot only 0.054
Cash Flow Adequacy snapshot only 1.912
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 2.61%
Dividend/Share $32.29 $33.02 $32.98 $32.96 $38.93 $39.46 $40.41 $41.43 $20.49 $20.01 $20.02 $20.02 $19.99 $20.02 $19.99 $19.96 $64.07 $64.86 $64.99 $66.42 $66.00
Payout Ratio 12.9% 13.4% 12.9% 12.8% 19.9% 24.4% 41.5% 52.2% 36.0% 43.1% — — — — 12.2% 9.2% 22.1% 16.3% 28.5% 37.7% 37.70%
FCF Payout Ratio 15.3% 18.7% 24.4% 32.7% 48.7% 40.9% 69.6% 1.4% — — — — — 86.3% 25.8% 6.4% 25.1% 25.1% 19.0% 36.3% 36.27%
Total Payout Ratio 43.0% 61.4% 59.0% 48.4% 41.1% 51.7% 1.6% 2.2% 2.7% 2.3% — — — — 12.2% 9.2% 22.1% 16.3% 28.5% 93.7% 93.67%
Div. Increase Streak 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.88 0.88 0.91 1.04 1.03 1.06 1.27 0.65 0.72 0.70 1.05 1.02 1.02 1.02 0.74 0.76 0.75 0.80 0.77 0.74 0.740
Interest Burden (EBT/EBIT) 0.99 0.97 0.98 0.95 0.93 0.95 0.71 0.83 0.77 0.72 1.37 -4.59 -14.57 -23.88 0.50 0.96 0.96 1.06 1.10 1.31 1.314
EBIT Margin 0.25 0.25 0.26 0.24 0.18 0.14 0.09 0.12 0.08 0.07 -0.15 0.04 0.02 0.01 0.33 0.20 0.26 0.30 0.19 0.13 0.133
Asset Turnover 0.46 0.42 0.41 0.39 0.40 0.40 0.40 0.39 0.40 0.40 0.42 0.40 0.40 0.39 0.45 0.45 0.46 1.09 0.45 0.41 0.407
Equity Multiplier 1.44 1.45 1.42 1.44 1.41 1.46 1.46 1.49 1.45 1.48 1.54 1.59 1.53 1.51 1.56 1.62 1.54 1.56 1.52 1.53 1.533
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $249.76 $246.21 $255.93 $257.58 $195.72 $161.61 $97.48 $79.37 $56.99 $46.38 $-266.40 $-257.58 $-271.57 $-297.12 $164.16 $216.66 $289.34 $397.36 $228.01 $176.20 $176.20
Book Value/Share $1918.13 $1903.80 $1925.33 $2029.98 $2011.38 $2026.54 $1961.24 $1986.16 $2090.15 $2099.89 $1811.25 $1878.79 $1903.20 $1858.30 $2056.51 $2164.85 $2404.56 $16.58 $2257.06 $2145.51 $2257.59
Tangible Book/Share $1813.20 $1644.19 $1644.14 $1771.84 $1748.51 $1661.63 $1389.27 $1339.80 $1435.66 $1442.71 $1355.27 $1417.50 $1436.82 $1387.49 $1583.35 $1714.57 $1956.60 $13.54 $1890.90 $1764.99 $1764.99
Revenue/Share $1166.64 $1150.49 $1122.72 $1104.04 $1109.11 $1143.54 $1163.56 $1209.06 $1222.79 $1245.66 $1236.39 $1227.95 $1207.28 $1184.05 $1338.93 $1468.68 $1536.37 $1588.73 $1455.99 $1361.34 $1426.04
FCF/Share $210.80 $176.96 $135.00 $100.75 $79.95 $96.44 $58.09 $28.92 $-57.87 $-144.12 $-173.59 $-192.13 $-83.03 $23.20 $77.46 $311.18 $255.13 $258.38 $341.68 $183.15 $145.13
OCF/Share $261.49 $231.88 $188.21 $155.02 $133.28 $151.47 $117.73 $96.86 $12.72 $-52.06 $-78.39 $-97.34 $2.01 $73.86 $117.52 $349.26 $285.86 $292.00 $395.31 $244.73 $214.60
Cash/Share $755.89 $649.69 $661.40 $662.52 $1079.90 $952.33 $903.55 $878.34 $795.30 $755.11 $681.76 $644.85 $639.95 $684.22 $660.69 $833.67 $797.20 $867.57 $875.49 $950.41 $841.15
EBITDA/Share $292.83 $292.28 $292.39 $308.94 $249.89 $207.23 $153.32 $193.58 $151.73 $143.64 $-123.14 $113.77 $74.82 $63.77 $486.16 $342.82 $453.62 $528.77 $329.37 $245.92 $245.92
Debt/Share $223.46 $251.76 $241.65 $238.48 $238.79 $378.37 $393.04 $404.69 $388.07 $390.45 $398.26 $399.68 $412.14 $398.72 $417.74 $433.50 $438.74 $413.18 $524.23 $142.34 $142.34
Net Debt/Share $-532.43 $-397.94 $-419.74 $-424.04 $-841.11 $-573.96 $-510.51 $-473.65 $-407.22 $-364.67 $-283.50 $-245.16 $-227.81 $-285.50 $-242.95 $-400.17 $-358.46 $-454.39 $-351.26 $-808.07 $-808.07
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 8 5 6 4 3 3 4 6 5 4 4 3 4 4 6 7 6 5 6 6 6
Beneish M-Score -2.47 -2.54 -2.43 -2.32 -2.36 -2.50 -2.52 -2.41 -2.33 -2.19 -2.62 -2.60 -2.91 -3.22 -1.84 -2.35 -2.16 -29.25 -2.97 -2.81 -2.806
Ohlson O-Score snapshot only -11.361
ROIC (Greenblatt) snapshot only 16.88%
Net-Net WC snapshot only $481.64
EVA snapshot only $6282942181.31
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only A+
Credit Score 82.75 82.75 82.75 79.55 80.55 76.55 63.55 68.65 62.35 61.75 50.00 54.15 45.65 47.65 79.65 75.25 80.25 73.75 80.25 75.25 75.250
Credit Grade snapshot only 5
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 125.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms